Malignant Biliary Obstruction

Malignant Biliary Obstruction
What is it?
Causes
Symptoms
Diagnosis
Treatment
References
Share

What is it?

What is “malignant biliary obstruction”?

Malignant biliary obstruction is a blockage or narrowing of the bile duct due to tumours. The bile duct is a tube that carries bile from the liver and gallbladder to the small intestine. The liver routinely produces bile which is stored in the gallbladder. Blockage of the duct prevents the liver from excreting bile, causing it to accumulate (‘cholestasis’) and back up into the bloodstream. As the bile accumulates in the blood, the bilirubin (a component of bile which is dark yellow in color) level in serum will increase causing yellowing of the skin and whites of the eyes. This symptom is called “jaundice” which is a common symptom of malignant biliary obstruction.

Causes

What cancer types are more likely to cause malignant biliary obstruction?

Any primary pancreatobiliary tract cancers and other local cancers that can cause compression of the biliary tract (e.g. liver, gallbladder) can cause malignant biliary obstruction. Cancers that are more commonly causing malignant biliary obstruction include:

  • Pancreatic cancer, especially at the head of pancreas
  • Cholangiocarcinoma (tumour of the bile duct)
  • Gallbladder cancer
  • Hepatocellular carcinoma
  • Cancer spreading to the lymph nodes causing compressing of the biliary tract
  • Neuroendocrine tumour

Symptoms

What are the symptoms of malignant biliary obstruction?

  • Jaundice – yellowing of the whites of the eyes or skin
  • Itchy skin
  • Dark yellow/ tea coloured urine
  • Pale, clay coloured stool
  • Foul-smelling, bulky, oily, floating stool
  • Unexplained weight loss, loss of appetite
  • Abdominal pain
  • Nausea and vomiting

Diagnosis

How to diagnose malignant biliary obstruction?

Your doctor will review your medical history and perform a physical examination. You will have blood tests and imaging to confirm the diagnosis and determine the cause of it.

  1. Blood test
    • Liver function test: The serum bilirubin is usually elevated and accompanied by elevations of the alkaline phosphatase (ALP) and gamma-glutamyl transpeptidase (GGT)
    • Tumour markers (CEA, CA 19): Tumour markers are non-specific and frequently elevated in both malignant and non-malignant cause of biliary tract obstruction or inflammation.
  2. Abdominal ultrasound
    • Abdominal ultrasound is a low cost and non-invasive procedure using ultrasound wave to show images inside the body. It can show any dilatation of the biliary tract.
    • However, if the malignant biliary obstruction is recent, the biliary tract may not be dilated.
    • Limitation of abdominal ultrasound: may not be able to accurately determine level and cause of obstruction, especially if the tumour is very small or located deep behind the peritoneum.
  3. Abdominal CT scan
    • CT scan offers multiplanar and cross-sectional imaging to visualise dilated bile ducts and identify the size, location and origin of the tumour. It also allows cancer staging, such as review for any liver or lymph node metastasis.
  4. Magnetic resonance cholangiopancreatography (MRCP)
    • MRCP is a kind of MRI which has excellent sensitivity and specificity in detecting malignant biliary obstruction. It is a non-invasive procedure can detect the location and extent of the obstruction.

Treatment

How to manage malignant biliary obstruction?

Methods to relieve the jaundice depends on the cause of obstruction of the biliary tract. Surgery or stent insertion can be used to relieve the obstruction.

1. Endoscopic retrograde cholangiopancreatography (ERCP) and stent

  • ERCP is the gold standard of imaging of the biliary tract and can serve as both diagnostic and therapeutic purpose.
  • Your doctor will put an endoscope which is a flexible tube with a camera into your mouth and pass into the duodenum for access to the bile duct. A smaller scope is then advanced into the bile duct. Dye is injected into the bile ducts and X-rays are taken to the locate the site of obstruction.
  • Biopsy is usually taken during the procedure to get a pathology to confirm the diagnosis.
  • A stent, either plastic or metallic, can be inserted at the site of blockage to allow the bile to drain into the intestine again. You will usually notice a benefit within 1-2 days after stent insertion.
  • The procedure is performed under anaesthesia and requires pre-operative fasting for 6-8 hours. Antibiotics is injected before the procedure to lower the risk of infection.
  • Risk of ERCP: biliary contamination (bacteria from the intestines enter the biliary system), pancreatitis, bleeding, allergic reaction to the anaesthetic agent or contrast dye, small bowel perforation, stent occlusion

 

2. Percutaneous transhepatic cholangiography (PTBD)

  • PTBD is performed if ERCP is unsuccessful or unavailable. It is a minimally invasive procedure where a thin tube called a catheter is inserted into the liver through a skin puncture. One end of the tube enters the bile duct, while the other remains outside the body. The bile is drained and collected in a bag outside your body.
  • This procedure is performed under local anaesthesia. Guided by ultrasound, a needle is inserted into the bile ducts within the liver. A contrast dye is then injected to visualise the biliary tree with X-Ray. A guidewire is then advanced past the area of obstruction at the biliary tract and a catheter is placed to drain the bile out.
  • Risks: bleeding, bile leakage, catheter dislodgement or blockage, infection due to skin penetration and indwelling foreign body, severe infection due to liver puncture, accidental puncturing of neighbouring organs such as arteries, lungs or bowels, contrast dye allergy.

 

3. Bypass surgery

  • If the patient is fit enough, a surgical procedure called biliary bypass may be an option of relieve the obstruction. Your doctor may perform a bypass surgery that connects the part of bile duct before and past the obstruction sites. For example, a bypass surgery that joins the common bile duct to the jejunum or a surgery that joins the biliary duct from the liver to the jejunum.
  • The surgery can be done by opening the abdomen or by keyhole surgery.

 

4. Radical operation

  • If the cancer is localised, your surgeon will discuss your case with oncologist and radiologist in multidisciplinary tumour board meeting to determine if radical surgery can be performed.
  • However, usually the jaundice needs to be relieved with lowering down of the serum bilirubin level before radical operation.
  • The type of operation depends on the site and local extent of the cancer.

 

5. Radiotherapy

  • If the tumour that causes biliary obstruction cannot be surgically removed, palliative radiotherapy can be given to relieve pain and potentially prolong the recurrence of obstruction after insertion of the stent.
  • You will first undergo radiotherapy planning. The radiation therapist will make some markings on your skin at the abdomen. A CT scan will be performed. Then your oncologist will use the CT scan to delineate the site for radiotherapy and determine the radiotherapy dose.
  • The duration of radiotherapy usually lasts for 2 to 5 weeks, depending on the total dosage of the radiotherapy.
  • Side effects of radiotherapy: skin reaction (redness or desquamation), stomach discomfort, dyspepsia, diarrhoea, malaise

 

6. Treatment of itchy skin

  • Itchy skin results from bile salt deposition in the skin.
  • General measures to improve the symptoms:
    • having a warm shower and using mild soap
    • applying moisturizing cream or lotions to the skin
    • keeping the room cool and humid
    • wearing loose-fitting clothing
    • avoiding wool clothing or fabrics that irritate skin
    • using antihistamine, e.g. cetirizine or piriton, to relieve the itchiness
  • Your doctor may prescribe cholestyramine to lower the bile salts in your body for relieving the discomfort.